{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T10:56:43Z","timestamp":1785495403096,"version":"3.56.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,2,2]],"date-time":"2021-02-02T00:00:00Z","timestamp":1612224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,2,2]],"date-time":"2021-02-02T00:00:00Z","timestamp":1612224000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Recent evidence suggests that a loss of expression of caveolin in the stromal compartment (sCav-1) of human invasive breast carcinoma (IBC) may be a predictor of disease recurrence, metastasis and poor outcome. At present, there is little knowledge regarding the expression of sCav-1 at the metastatic sites. We therefore studied sCav-1 expression in IBCs and in their axillary lymph nodes to seek a correlation with cancer metastasis. 189 consecutive invasive IBCs (53 with axillary lymph node metastases and 136 without) were studied by immunohistochemistry, using a rabbit polyclonal anti-Cav-1 antibody. In IBCs sCav-1 was evaluated in fibroblasts scattered in the tumor stroma whereas in lymph nodes sCav-1 was assessed in fibroblast-like stromal cells. For the first time, we observed a statistically significant progressive loss of sCav-1 from normal\/reactive axillary lymph nodes of tumors limited to the breast to metastatic axillary lymph nodes, through normal\/reactive axillary lymph nodes of tumors with axillary metastatic spread. These data indicate that Cav-1 expressed by the stromal compartment of lymph nodes, somehow, may possibly contribute to metastatic spread in IBC.<\/jats:p>","DOI":"10.1038\/s41598-021-82405-y","type":"journal-article","created":{"date-parts":[[2021,2,2]],"date-time":"2021-02-02T13:21:09Z","timestamp":1612272069000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["New insights in the expression of stromal caveolin 1 in breast cancer spread to axillary lymph nodes"],"prefix":"10.1038","volume":"11","author":[{"given":"Cristian","family":"Scatena","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Fanelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe Nicol\u00f2","family":"Fanelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Menicagli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Aretini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valerio","family":"Ortenzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara Piera","family":"Civitelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenzo","family":"Innocenti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Sotgia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael P.","family":"Lisanti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio Giuseppe","family":"Naccarato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,2,2]]},"reference":[{"key":"82405_CR1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers10120506","author":"E Nicolas","year":"2018","unstructured":"Nicolas, E., Bertucci, F., Sabatier, R. & Goncalves, A. Targeting BRCA deficiency in breast cancer: what are the clinical evidences and the next perspectives?. Cancers (Basel). https:\/\/doi.org\/10.3390\/cancers10120506 (2018).","journal-title":"Cancers (Basel)."},{"key":"82405_CR2","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1038\/sj.bjc.6604463","volume":"99","author":"SE Elsheikh","year":"2008","unstructured":"Elsheikh, S. E. et al. Caveolin 1 and Caveolin 2 are associated with breast cancer basal-like and triple-negative immunophenotype. Br. J. Cancer 99, 327\u2013334. https:\/\/doi.org\/10.1038\/sj.bjc.6604463 (2008).","journal-title":"Br. J. Cancer"},{"key":"82405_CR3","doi-asserted-by":"publisher","first-page":"1923","DOI":"10.1016\/j.febslet.2009.12.039","volume":"584","author":"F Blasi","year":"2010","unstructured":"Blasi, F. & Sidenius, N. The urokinase receptor: Focused cell surface proteolysis, cell adhesion and signaling. FEBS Lett. 584, 1923\u20131930. https:\/\/doi.org\/10.1016\/j.febslet.2009.12.039 (2010).","journal-title":"FEBS Lett."},{"key":"82405_CR4","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1038\/nrc1877","volume":"6","author":"R Kalluri","year":"2006","unstructured":"Kalluri, R. & Zeisberg, M. Fibroblasts in cancer. Nat. Rev. Cancer 6, 392\u2013401. https:\/\/doi.org\/10.1038\/nrc1877 (2006).","journal-title":"Nat. Rev. Cancer"},{"key":"82405_CR5","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1007\/s10555-012-9373-9","volume":"31","author":"JP Sleeman","year":"2012","unstructured":"Sleeman, J. P. The metastatic niche and stromal progression. Cancer Metastasis Rev. 31, 429\u2013440. https:\/\/doi.org\/10.1007\/s10555-012-9373-9 (2012).","journal-title":"Cancer Metastasis Rev."},{"key":"82405_CR6","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1038\/nature04186","volume":"438","author":"RN Kaplan","year":"2005","unstructured":"Kaplan, R. N. et al. VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche. Nature 438, 820\u2013827. https:\/\/doi.org\/10.1038\/nature04186 (2005).","journal-title":"Nature"},{"key":"82405_CR7","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/0962-8924(94)90114-7","volume":"4","author":"MP Lisanti","year":"1994","unstructured":"Lisanti, M. P., Scherer, P. E., Tang, Z. & Sargiacomo, M. Caveolae, caveolin and caveolin-rich membrane domains: a signalling hypothesis. Trends Cell Biol. 4, 231\u2013235. https:\/\/doi.org\/10.1016\/0962-8924(94)90114-7 (1994).","journal-title":"Trends Cell Biol."},{"key":"82405_CR8","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.3892\/ol.2014.2385","volume":"8","author":"D Chen","year":"2014","unstructured":"Chen, D. & Che, G. Value of caveolin-1 in cancer progression and prognosis: Emphasis on cancer-associated fibroblasts, human cancer cells and mechanism of caveolin-1 expression (review). Oncol. Lett. 8, 1409\u20131421. https:\/\/doi.org\/10.3892\/ol.2014.2385 (2014).","journal-title":"Oncol. Lett."},{"key":"82405_CR9","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1080\/07853890410018899","volume":"36","author":"TM Williams","year":"2004","unstructured":"Williams, T. M. & Lisanti, M. P. The Caveolin genes: From cell biology to medicine. Ann. Med. 36, 584\u2013595. https:\/\/doi.org\/10.1080\/07853890410018899 (2004).","journal-title":"Ann. Med."},{"key":"82405_CR10","doi-asserted-by":"publisher","first-page":"20163","DOI":"10.1016\/S0021-9258(19)47038-5","volume":"264","author":"JR Glenney Jr","year":"1989","unstructured":"Glenney, J. R. Jr. Tyrosine phosphorylation of a 22-kDa protein is correlated with transformation by Rous sarcoma virus. J. Biol. Chem. 264, 20163\u201320166 (1989).","journal-title":"J. Biol. Chem."},{"key":"82405_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10549-011-1751-4","volume":"131","author":"N Patani","year":"2012","unstructured":"Patani, N., Martin, L. A., Reis-Filho, J. S. & Dowsett, M. The role of caveolin-1 in human breast cancer. Breast Cancer Res. Treat. 131, 1\u201315. https:\/\/doi.org\/10.1007\/s10549-011-1751-4 (2012).","journal-title":"Breast Cancer Res. Treat."},{"key":"82405_CR12","first-page":"2361","volume":"61","author":"K Hayashi","year":"2001","unstructured":"Hayashi, K. et al. Invasion activating caveolin-1 mutation in human scirrhous breast cancers. Cancer Res. 61, 2361\u20132364 (2001).","journal-title":"Cancer Res."},{"key":"82405_CR13","first-page":"5168","volume":"61","author":"DA Zajchowski","year":"2001","unstructured":"Zajchowski, D. A. et al. Identification of gene expression profiles that predict the aggressive behavior of breast cancer cells. Cancer Res. 61, 5168\u20135178 (2001).","journal-title":"Cancer Res."},{"key":"82405_CR14","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.4161\/cbt.7.8.6220","volume":"7","author":"I Mercier","year":"2008","unstructured":"Mercier, I. et al. Human breast cancer-associated fibroblasts (CAFs) show caveolin-1 downregulation and RB tumor suppressor functional inactivation: Implications for the response to hormonal therapy. Cancer Biol. Ther. 7, 1212\u20131225. https:\/\/doi.org\/10.4161\/cbt.7.8.6220 (2008).","journal-title":"Cancer Biol. Ther."},{"key":"82405_CR15","doi-asserted-by":"publisher","first-page":"2023","DOI":"10.2353\/ajpath.2009.080873","volume":"174","author":"AK Witkiewicz","year":"2009","unstructured":"Witkiewicz, A. K. et al. An absence of stromal caveolin-1 expression predicts early tumor recurrence and poor clinical outcome in human breast cancers. Am. J. Pathol. 174, 2023\u20132034. https:\/\/doi.org\/10.2353\/ajpath.2009.080873 (2009).","journal-title":"Am. J. Pathol."},{"key":"82405_CR16","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1007\/s00428-014-1614-6","volume":"465","author":"M Ren","year":"2014","unstructured":"Ren, M. et al. Absence of caveolin-1 expression in carcinoma-associated fibroblasts of invasive micropapillary carcinoma of the breast predicts poor patient outcome. Virchows Arch. 465, 291\u2013298. https:\/\/doi.org\/10.1007\/s00428-014-1614-6 (2014).","journal-title":"Virchows Arch."},{"key":"82405_CR17","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/s12253-017-0212-8","volume":"24","author":"N Eliyatkin","year":"2018","unstructured":"Eliyatkin, N. et al. Expression of stromal Caveolin-1 may be a predictor for aggressive behaviour of breast cancer. Pathol. Oncol. Res. 24, 59\u201365. https:\/\/doi.org\/10.1007\/s12253-017-0212-8 (2018).","journal-title":"Pathol. Oncol. Res."},{"key":"82405_CR18","doi-asserted-by":"publisher","first-page":"2035","DOI":"10.2353\/ajpath.2009.080924","volume":"174","author":"EK Sloan","year":"2009","unstructured":"Sloan, E. K. et al. Stromal cell expression of caveolin-1 predicts outcome in breast cancer. Am. J. Pathol. 174, 2035\u20132043. https:\/\/doi.org\/10.2353\/ajpath.2009.080924 (2009).","journal-title":"Am. J. Pathol."},{"key":"82405_CR19","doi-asserted-by":"publisher","first-page":"135","DOI":"10.4161\/cbt.10.2.11983","volume":"10","author":"AK Witkiewicz","year":"2010","unstructured":"Witkiewicz, A. K. et al. Loss of stromal caveolin-1 expression predicts poor clinical outcome in triple negative and basal-like breast cancers. Cancer Biol. Ther. 10, 135\u2013143. https:\/\/doi.org\/10.4161\/cbt.10.2.11983 (2010).","journal-title":"Cancer Biol. Ther."},{"key":"82405_CR20","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.4161\/cbt.8.11.8874","volume":"8","author":"AK Witkiewicz","year":"2009","unstructured":"Witkiewicz, A. K. et al. Stromal caveolin-1 levels predict early DCIS progression to invasive breast cancer. Cancer Biol. Ther. 8, 1071\u20131079. https:\/\/doi.org\/10.4161\/cbt.8.11.8874 (2009).","journal-title":"Cancer Biol. Ther."},{"key":"82405_CR21","first-page":"1873","volume":"4","author":"G Yang","year":"1998","unstructured":"Yang, G. et al. Elevated expression of caveolin is associated with prostate and breast cancer. Clin. Cancer Res. 4, 1873\u20131880 (1998).","journal-title":"Clin. Cancer Res."},{"key":"82405_CR22","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1158\/1078-0432.CCR-06-1371","volume":"13","author":"K Savage","year":"2007","unstructured":"Savage, K. et al. Caveolin 1 is overexpressed and amplified in a subset of basal-like and metaplastic breast carcinomas: A morphologic, ultrastructural, immunohistochemical, and in situ hybridization analysis. Clin. Cancer Res. 13, 90\u2013101. https:\/\/doi.org\/10.1158\/1078-0432.CCR-06-1371 (2007).","journal-title":"Clin. Cancer Res."},{"key":"82405_CR23","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1007\/s10549-006-9184-1","volume":"99","author":"SM Pinilla","year":"2006","unstructured":"Pinilla, S. M., Honrado, E., Hardisson, D., Benitez, J. & Palacios, J. Caveolin-1 expression is associated with a basal-like phenotype in sporadic and hereditary breast cancer. Breast Cancer Res. Treat. 99, 85\u201390. https:\/\/doi.org\/10.1007\/s10549-006-9184-1 (2006).","journal-title":"Breast Cancer Res. Treat."},{"key":"82405_CR24","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1186\/1477-7819-5-110","volume":"5","author":"C Liedtke","year":"2007","unstructured":"Liedtke, C., Kersting, C., Burger, H., Kiesel, L. & Wulfing, P. Caveolin-1 expression in benign and malignant lesions of the breast. World J. Surg. Oncol. 5, 110. https:\/\/doi.org\/10.1186\/1477-7819-5-110 (2007).","journal-title":"World J. Surg. Oncol."},{"key":"82405_CR25","doi-asserted-by":"publisher","unstructured":"Hurlstone, A.F. et al. Analysis of the CAVEOLIN-1 gene at human chromosome 7q31.1 in primary tumours and tumour-derived cell lines. Oncogene 18, 1881\u20131890, https:\/\/doi.org\/10.1038\/sj.onc.1202491 (1999).","DOI":"10.1038\/sj.onc.1202491"},{"key":"82405_CR26","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.semcancer.2012.02.007","volume":"22","author":"JP Sleeman","year":"2012","unstructured":"Sleeman, J. P. et al. Concepts of metastasis in flux: The stromal progression model. Semin. Cancer Biol. 22, 174\u2013186. https:\/\/doi.org\/10.1016\/j.semcancer.2012.02.007 (2012).","journal-title":"Semin. Cancer Biol."},{"key":"82405_CR27","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1007\/s10585-014-9645-6","volume":"31","author":"L Alevizos","year":"2014","unstructured":"Alevizos, L. et al. Breast cancer nodal metastasis correlates with tumour and lymph node methylation profiles of Caveolin-1 and CXCR4. Clin. Exp. Metastasis 31, 511\u2013520. https:\/\/doi.org\/10.1007\/s10585-014-9645-6 (2014).","journal-title":"Clin. Exp. Metastasis"},{"key":"82405_CR28","doi-asserted-by":"publisher","first-page":"2842","DOI":"10.1016\/j.celrep.2017.11.034","volume":"21","author":"W Celus","year":"2017","unstructured":"Celus, W. et al. Loss of caveolin-1 in metastasis-associated macrophages drives lung metastatic growth through increased angiogenesis. Cell Rep. 21, 2842\u20132854. https:\/\/doi.org\/10.1016\/j.celrep.2017.11.034 (2017).","journal-title":"Cell Rep."},{"key":"82405_CR29","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1038\/nm.4400","volume":"23","author":"M Murgai","year":"2017","unstructured":"Murgai, M. et al. KLF4-dependent perivascular cell plasticity mediates pre-metastatic niche formation and metastasis. Nat. Med. 23, 1176\u20131190. https:\/\/doi.org\/10.1038\/nm.4400 (2017).","journal-title":"Nat. Med."},{"key":"82405_CR30","doi-asserted-by":"publisher","first-page":"2360","DOI":"10.1242\/jcs.014977","volume":"121","author":"F Shi","year":"2008","unstructured":"Shi, F. & Sottile, J. Caveolin-1-dependent beta1 integrin endocytosis is a critical regulator of fibronectin turnover. J. Cell Sci. 121, 2360\u20132371. https:\/\/doi.org\/10.1242\/jcs.014977 (2008).","journal-title":"J. Cell Sci."},{"key":"82405_CR31","doi-asserted-by":"publisher","first-page":"1794","DOI":"10.3389\/fimmu.2017.01794","volume":"8","author":"C Oyarce","year":"2017","unstructured":"Oyarce, C. et al. Caveolin-1 expression increases upon maturation in dendritic cells and promotes their migration to lymph nodes thereby favoring the induction of CD8(+) T cell responses. Front. Immunol. 8, 1794. https:\/\/doi.org\/10.3389\/fimmu.2017.01794 (2017).","journal-title":"Front. Immunol."},{"key":"82405_CR32","doi-asserted-by":"publisher","first-page":"1794","DOI":"10.4161\/cc.10.11.15675","volume":"10","author":"AK Witkiewicz","year":"2011","unstructured":"Witkiewicz, A. K. et al. Molecular profiling of a lethal tumor microenvironment, as defined by stromal caveolin-1 status in breast cancers. Cell Cycle 10, 1794\u20131809. https:\/\/doi.org\/10.4161\/cc.10.11.15675 (2011).","journal-title":"Cell Cycle"},{"key":"82405_CR33","doi-asserted-by":"publisher","first-page":"3984","DOI":"10.4161\/cc.8.23.10238","volume":"8","author":"S Pavlides","year":"2009","unstructured":"Pavlides, S. et al. The reverse Warburg effect: Aerobic glycolysis in cancer associated fibroblasts and the tumor stroma. Cell Cycle 8, 3984\u20134001. https:\/\/doi.org\/10.4161\/cc.8.23.10238 (2009).","journal-title":"Cell Cycle"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-82405-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-82405-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-82405-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,3]],"date-time":"2022-12-03T02:52:48Z","timestamp":1670035968000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-82405-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,2]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["82405"],"URL":"https:\/\/doi.org\/10.1038\/s41598-021-82405-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,2]]},"assertion":[{"value":"9 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 January 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 February 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2755"}}